
Company Number
06032554
Next Accounts
Sep 2025
Shareholders
stampdew ltd
Group Structure
View All
Industry
Book publishing
+2Registered Address
the campus 4 crinan street, london, N1 9XW
Website
www.springerhealthcare.comPomanda estimates the enterprise value of SPRINGER HEALTHCARE LTD. at £32.5m based on a Turnover of £22.6m and 1.44x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of SPRINGER HEALTHCARE LTD. at £31.1m based on an EBITDA of £4.1m and a 7.64x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of SPRINGER HEALTHCARE LTD. at £39.4m based on Net Assets of £20.1m and 1.96x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Springer Healthcare Ltd. is a live company located in london, N1 9XW with a Companies House number of 06032554. It operates in the book publishing sector, SIC Code 58110. Founded in December 2006, it's largest shareholder is stampdew ltd with a 100% stake. Springer Healthcare Ltd. is a established, large sized company, Pomanda has estimated its turnover at £22.6m with low growth in recent years.
Pomanda's financial health check has awarded Springer Healthcare Ltd. a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 3 areas for improvement. Company Health Check FAQs
7 Strong
1 Regular
3 Weak
Size
annual sales of £22.6m, make it larger than the average company (£2.5m)
£22.6m - Springer Healthcare Ltd.
£2.5m - Industry AVG
Growth
3 year (CAGR) sales growth of 2%, show it is growing at a slower rate (4.1%)
2% - Springer Healthcare Ltd.
4.1% - Industry AVG
Production
with a gross margin of 80.6%, this company has a lower cost of product (56.8%)
80.6% - Springer Healthcare Ltd.
56.8% - Industry AVG
Profitability
an operating margin of 17.7% make it more profitable than the average company (8.5%)
17.7% - Springer Healthcare Ltd.
8.5% - Industry AVG
Employees
with 157 employees, this is above the industry average (23)
157 - Springer Healthcare Ltd.
23 - Industry AVG
Pay Structure
on an average salary of £82.2k, the company has a higher pay structure (£53k)
£82.2k - Springer Healthcare Ltd.
£53k - Industry AVG
Efficiency
resulting in sales per employee of £144k, this is equally as efficient (£155.6k)
£144k - Springer Healthcare Ltd.
£155.6k - Industry AVG
Debtor Days
it gets paid by customers after 78 days, this is later than average (46 days)
78 days - Springer Healthcare Ltd.
46 days - Industry AVG
Creditor Days
its suppliers are paid after 67 days, this is slower than average (42 days)
67 days - Springer Healthcare Ltd.
42 days - Industry AVG
Stock Days
it holds stock equivalent to 18 days, this is less than average (39 days)
18 days - Springer Healthcare Ltd.
39 days - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Springer Healthcare Ltd.
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 34.7%, this is a lower level of debt than the average (43.2%)
34.7% - Springer Healthcare Ltd.
43.2% - Industry AVG
Springer Healthcare Ltd.'s latest turnover from December 2023 is £22.6 million and the company has net assets of £20.1 million. According to their latest financial statements, Springer Healthcare Ltd. has 157 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 22,602,000 | 23,553,000 | 22,633,000 | 21,320,000 | 19,500,000 | 20,902,000 | 18,122,000 | 15,581,000 | 12,953,000 | 12,919,000 | 11,391,000 | 7,312,000 | 10,216,000 | 9,595,000 | 5,395,000 |
Other Income Or Grants | |||||||||||||||
Cost Of Sales | 4,384,000 | 5,210,000 | 5,698,000 | 6,455,000 | 5,514,000 | 7,178,000 | 5,713,000 | 5,813,000 | 4,372,000 | 5,439,000 | 4,364,000 | 2,930,000 | 3,707,000 | 3,346,000 | 2,208,000 |
Gross Profit | 18,218,000 | 18,343,000 | 16,935,000 | 14,865,000 | 13,986,000 | 13,724,000 | 12,409,000 | 9,768,000 | 8,581,000 | 7,480,000 | 7,027,000 | 4,382,000 | 6,509,000 | 6,249,000 | 3,187,000 |
Admin Expenses | 14,228,000 | 13,090,000 | 11,158,000 | 9,768,000 | 9,607,000 | 9,803,000 | 8,984,000 | 7,152,000 | 8,136,000 | 7,353,000 | 6,673,000 | 8,985,000 | 6,326,000 | 6,326,000 | 3,769,000 |
Operating Profit | 3,990,000 | 5,253,000 | 5,777,000 | 5,097,000 | 4,379,000 | 3,921,000 | 3,425,000 | 2,616,000 | 445,000 | 127,000 | 354,000 | -4,603,000 | 183,000 | -77,000 | -582,000 |
Interest Payable | 5,000 | 1,000 | 1,000 | 19,000 | 180,000 | 257,000 | 328,000 | 474,000 | 574,000 | 668,000 | 693,000 | 473,000 | 416,000 | 346,000 | 80,000 |
Interest Receivable | 1,431,000 | 599,000 | 238,000 | 104,000 | 96,000 | 75,000 | 55,000 | 36,000 | 32,000 | 5,000 | 47,000 | 2,000 | 2,000 | 2,000 | 3,000 |
Pre-Tax Profit | 5,416,000 | 5,850,000 | 6,014,000 | 5,182,000 | 4,295,000 | 3,739,000 | 3,152,000 | 2,178,000 | -97,000 | -536,000 | -292,000 | -5,074,000 | -231,000 | -421,000 | -659,000 |
Tax | -1,582,000 | -1,176,000 | -1,165,000 | -1,070,000 | -995,000 | -877,000 | -664,000 | -457,000 | -204,000 | 138,000 | 561,000 | 298,000 | -1,000 | ||
Profit After Tax | 3,834,000 | 4,674,000 | 4,849,000 | 4,112,000 | 3,300,000 | 2,862,000 | 2,488,000 | 1,721,000 | -301,000 | -398,000 | 269,000 | -4,776,000 | -232,000 | -421,000 | -659,000 |
Dividends Paid | |||||||||||||||
Retained Profit | 3,834,000 | 4,674,000 | 4,849,000 | 4,112,000 | 3,300,000 | 2,862,000 | 2,488,000 | 1,721,000 | -301,000 | -398,000 | 269,000 | -4,776,000 | -232,000 | -421,000 | -659,000 |
Employee Costs | 12,903,000 | 10,459,000 | 9,270,000 | 9,159,000 | 8,887,000 | 8,466,000 | 8,356,000 | 6,329,000 | 5,833,000 | 5,668,000 | 5,059,000 | 3,340,000 | 3,352,000 | 3,301,000 | 1,579,000 |
Number Of Employees | 157 | 143 | 141 | 136 | 135 | 135 | 124 | 115 | 108 | 112 | 96 | 68 | 73 | 74 | 59 |
EBITDA* | 4,072,000 | 5,463,000 | 6,084,000 | 5,459,000 | 4,846,000 | 4,440,000 | 3,724,000 | 2,765,000 | 708,000 | 504,000 | 497,000 | -1,366,000 | 973,000 | 739,000 | -87,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 116,000 | 152,000 | 840,000 | 381,000 | 633,000 | 869,000 | 260,000 | 89,000 | 115,000 | 138,000 | 405,000 | 149,000 | 186,000 | 193,000 | 236,000 |
Intangible Assets | 475,000 | 604,000 | 8,000 | 36,000 | 79,000 | 258,000 | 409,000 | 636,000 | 376,000 | 261,000 | 173,000 | 80,000 | 3,140,000 | 3,871,000 | 4,606,000 |
Investments & Other | |||||||||||||||
Debtors (Due After 1 year) | |||||||||||||||
Total Fixed Assets | 591,000 | 756,000 | 848,000 | 417,000 | 712,000 | 1,127,000 | 669,000 | 725,000 | 491,000 | 399,000 | 578,000 | 229,000 | 3,326,000 | 4,064,000 | 4,842,000 |
Stock & work in progress | 222,000 | 302,000 | 382,000 | 259,000 | 197,000 | 177,000 | 393,000 | 188,000 | 135,000 | 182,000 | 100,000 | 106,000 | 98,000 | 77,000 | 58,000 |
Trade Debtors | 4,832,000 | 4,825,000 | 6,035,000 | 4,733,000 | 5,920,000 | 5,117,000 | 5,489,000 | 4,510,000 | 3,112,000 | 4,065,000 | 4,164,000 | 1,510,000 | 2,455,000 | 2,978,000 | 2,049,000 |
Group Debtors | 24,221,000 | 20,962,000 | 16,366,000 | 10,430,000 | 5,554,000 | 5,498,000 | 4,331,000 | 4,993,000 | 3,674,000 | 5,422,000 | 4,994,000 | 663,000 | 321,000 | 88,000 | 3,648,000 |
Misc Debtors | 901,000 | 1,139,000 | 414,000 | 364,000 | 642,000 | 388,000 | 528,000 | 386,000 | 603,000 | 1,055,000 | 1,161,000 | 434,000 | 497,000 | 255,000 | 262,000 |
Cash | 19,000 | 12,000 | 36,000 | 36,000 | 176,000 | 649,000 | 202,000 | 47,000 | 84,000 | 16,000 | |||||
misc current assets | |||||||||||||||
total current assets | 30,176,000 | 27,228,000 | 23,197,000 | 15,786,000 | 12,313,000 | 11,199,000 | 10,753,000 | 10,113,000 | 7,560,000 | 10,900,000 | 11,068,000 | 2,915,000 | 3,418,000 | 3,482,000 | 6,033,000 |
total assets | 30,767,000 | 27,984,000 | 24,045,000 | 16,203,000 | 13,025,000 | 12,326,000 | 11,422,000 | 10,838,000 | 8,051,000 | 11,299,000 | 11,646,000 | 3,144,000 | 6,744,000 | 7,546,000 | 10,875,000 |
Bank overdraft | 5,000 | 15,000 | 27,000 | 27,000 | 20,000 | 31,000 | 49,000 | ||||||||
Bank loan | |||||||||||||||
Trade Creditors | 811,000 | 750,000 | 443,000 | 750,000 | 736,000 | 592,000 | 1,109,000 | 779,000 | 880,000 | 1,126,000 | 947,000 | 401,000 | 769,000 | 999,000 | 535,000 |
Group/Directors Accounts | 431,000 | 2,742,000 | 2,588,000 | 1,175,000 | 3,796,000 | 7,222,000 | 9,893,000 | 12,560,000 | 12,781,000 | 15,117,000 | 14,965,000 | 9,126,000 | 7,377,000 | 6,918,000 | 10,051,000 |
other short term finances | |||||||||||||||
hp & lease commitments | |||||||||||||||
other current liabilities | 9,423,000 | 8,224,000 | 9,420,000 | 7,533,000 | 5,860,000 | 5,179,000 | 3,949,000 | 3,591,000 | 2,386,000 | 2,703,000 | 2,938,000 | 1,084,000 | 1,296,000 | 2,084,000 | 2,305,000 |
total current liabilities | 10,665,000 | 11,716,000 | 12,451,000 | 9,458,000 | 10,392,000 | 12,993,000 | 14,951,000 | 16,930,000 | 16,052,000 | 18,961,000 | 18,877,000 | 10,638,000 | 9,462,000 | 10,032,000 | 12,940,000 |
loans | |||||||||||||||
hp & lease commitments | |||||||||||||||
Accruals and Deferred Income | |||||||||||||||
other liabilities | |||||||||||||||
provisions | |||||||||||||||
total long term liabilities | |||||||||||||||
total liabilities | 10,665,000 | 11,716,000 | 12,451,000 | 9,458,000 | 10,392,000 | 12,993,000 | 14,951,000 | 16,930,000 | 16,052,000 | 18,961,000 | 18,877,000 | 10,638,000 | 9,462,000 | 10,032,000 | 12,940,000 |
net assets | 20,102,000 | 16,268,000 | 11,594,000 | 6,745,000 | 2,633,000 | -667,000 | -3,529,000 | -6,092,000 | -8,001,000 | -7,662,000 | -7,231,000 | -7,494,000 | -2,718,000 | -2,486,000 | -2,065,000 |
total shareholders funds | 20,102,000 | 16,268,000 | 11,594,000 | 6,745,000 | 2,633,000 | -667,000 | -3,529,000 | -6,092,000 | -8,001,000 | -7,662,000 | -7,231,000 | -7,494,000 | -2,718,000 | -2,486,000 | -2,065,000 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | 3,990,000 | 5,253,000 | 5,777,000 | 5,097,000 | 4,379,000 | 3,921,000 | 3,425,000 | 2,616,000 | 445,000 | 127,000 | 354,000 | -4,603,000 | 183,000 | -77,000 | -582,000 |
Depreciation | 77,000 | 209,000 | 279,000 | 319,000 | 367,000 | 340,000 | 99,000 | 66,000 | 69,000 | 70,000 | 95,000 | 59,000 | 57,000 | 79,000 | 29,000 |
Amortisation | 5,000 | 1,000 | 28,000 | 43,000 | 100,000 | 179,000 | 200,000 | 83,000 | 194,000 | 307,000 | 48,000 | 3,178,000 | 733,000 | 737,000 | 466,000 |
Tax | -1,582,000 | -1,176,000 | -1,165,000 | -1,070,000 | -995,000 | -877,000 | -664,000 | -457,000 | -204,000 | 138,000 | 561,000 | 298,000 | -1,000 | ||
Stock | -80,000 | -80,000 | 123,000 | 62,000 | 20,000 | -216,000 | 205,000 | 53,000 | -47,000 | 82,000 | -6,000 | 8,000 | 21,000 | 19,000 | 58,000 |
Debtors | 3,028,000 | 4,111,000 | 7,288,000 | 3,411,000 | 1,113,000 | 655,000 | 459,000 | 2,500,000 | -3,153,000 | 223,000 | 7,712,000 | -666,000 | -48,000 | -2,638,000 | 5,959,000 |
Creditors | 61,000 | 307,000 | -307,000 | 14,000 | 144,000 | -517,000 | 330,000 | -101,000 | -246,000 | 179,000 | 546,000 | -368,000 | -230,000 | 464,000 | 535,000 |
Accruals and Deferred Income | 1,199,000 | -1,196,000 | 1,887,000 | 1,673,000 | 681,000 | 1,230,000 | 358,000 | 1,205,000 | -317,000 | -235,000 | 1,854,000 | -212,000 | -788,000 | -221,000 | 2,305,000 |
Deferred Taxes & Provisions | |||||||||||||||
Cash flow from operations | 802,000 | -633,000 | -912,000 | 2,603,000 | 3,543,000 | 3,837,000 | 3,084,000 | 859,000 | 3,141,000 | 281,000 | -4,248,000 | -990,000 | -19,000 | 3,601,000 | -3,264,000 |
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | |||||||||||||||
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | |||||||||||||||
Group/Directors Accounts | -2,311,000 | 154,000 | 1,413,000 | -2,621,000 | -3,426,000 | -2,671,000 | -2,667,000 | -221,000 | -2,336,000 | 152,000 | 5,839,000 | 1,749,000 | 459,000 | -3,133,000 | 10,051,000 |
Other Short Term Loans | |||||||||||||||
Long term loans | |||||||||||||||
Hire Purchase and Lease Commitments | |||||||||||||||
other long term liabilities | |||||||||||||||
share issue | |||||||||||||||
interest | 1,426,000 | 598,000 | 237,000 | 85,000 | -84,000 | -182,000 | -273,000 | -438,000 | -542,000 | -663,000 | -646,000 | -471,000 | -414,000 | -344,000 | -77,000 |
cash flow from financing | -885,000 | 752,000 | 1,650,000 | -2,536,000 | -3,510,000 | -2,853,000 | -2,865,000 | -471,000 | -2,916,000 | -544,000 | 5,187,000 | 1,278,000 | 45,000 | -3,477,000 | 8,568,000 |
cash and cash equivalents | |||||||||||||||
cash | -19,000 | 7,000 | -24,000 | -140,000 | -473,000 | 447,000 | 155,000 | -37,000 | 68,000 | 16,000 | |||||
overdraft | -5,000 | -10,000 | -12,000 | 7,000 | -11,000 | -18,000 | 49,000 | ||||||||
change in cash | -19,000 | 7,000 | -24,000 | 5,000 | -130,000 | -461,000 | 447,000 | 148,000 | -26,000 | 86,000 | -33,000 |
Perform a competitor analysis for springer healthcare ltd. by selecting its closest rivals, whether from the INFORMATION AND COMMUNICATION sector, other large companies, companies in N 1 area or any other competitors across 12 key performance metrics.
SPRINGER HEALTHCARE LTD. group structure
Springer Healthcare Ltd. has 1 subsidiary company.
Ultimate parent company
SPRINGER NATURE AG & CO KGAA
#0103639
2 parents
SPRINGER HEALTHCARE LTD.
06032554
1 subsidiary
Springer Healthcare Ltd. currently has 4 directors. The longest serving directors include Ms Rachel Jacobs (Apr 2016) and Mr Steven Inchcoombe (May 2016).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Ms Rachel Jacobs | England | 49 years | Apr 2016 | - | Director |
Mr Steven Inchcoombe | 60 years | May 2016 | - | Director | |
Ms Carolyn Honour | United Kingdom | 65 years | Jun 2017 | - | Director |
Mr Joachim Krieger | United Kingdom | 61 years | Jan 2024 | - | Director |
P&L
December 2023turnover
22.6m
-4%
operating profit
4m
-24%
gross margin
80.7%
+3.5%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
20.1m
+0.24%
total assets
30.8m
+0.1%
cash
0
0%
net assets
Total assets minus all liabilities
company number
06032554
Type
Private limited with Share Capital
industry
58190 - Other publishing activities
58110 - Book publishing
58141 - Publishing of learned journals
incorporation date
December 2006
age
19
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
springer healthcare communications limited (November 2009)
accountant
-
auditor
ERNST & YOUNG LLP
address
the campus 4 crinan street, london, N1 9XW
Bank
-
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to springer healthcare ltd..
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for SPRINGER HEALTHCARE LTD.. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|